5AM Ventures IV, L.P. 4
4 · Crinetics Pharmaceuticals, Inc. · Filed Jun 25, 2019
Insider Transaction Report
Form 4
5AM Ventures IV, L.P.
10% Owner
Transactions
- Sale
Common Stock
2019-06-21$22.20/sh−10,000$222,000→ 94,489 total(indirect: See footote) - Sale
Common Stock
2019-06-21$22.20/sh−240,000$5,328,000→ 2,267,797 total(indirect: See footote)
Footnotes (2)
- [F1]These securities are held by by 5AM Ventures IV, L.P. ("Ventures IV"). 5AM Partners IV, LLC ("Partners IV") is the sole general partner of Ventures IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Partners IV, and have shared voting and investment power over the shares beneficially owned by Ventures IV. Each of Partners IV, Dr. Diekman, Mr. Schwab, and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or their pecuniary interest therein.
- [F2]These securities are held by 5AM Co-Investors IV, L.P. ("Co-Investors IV"). Partners IV is the sole general partner of Co-Investors IV. Dr. John Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are the managing members of Co-Investors IV, and have shared voting and investment power over the shares beneficially owned by Co-Investors IV. Each of Partners IV, Dr. Diekman, Mr. Schwab, and Dr. Rocklage disclaims beneficial ownership of such shares except to the extent of its or their pecuniary interest therein.